premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O’Reilly

CGEM is a unique pharmaceutical company that collaborates with other developers and academia to develop drugs to help cancer patients.  It has six on-going products in its pipeline.  It trades below book value, at 6x earnings, and supports a 19% ROE.  We like that it is low beta compared to the market.  We recommend a stop-loss at $8.50, looking to achieve $17 — upside potential of 50%.  Yield 0%

(Analysts’ price target is $28.75)
biotechnology / pharmaceutical
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Cullinan Oncology, Inc.(CGEM-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Cullinan Oncology, Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Cullinan Oncology, Inc.(CGEM-Q) Frequently Asked Questions

What is Cullinan Oncology, Inc. stock symbol?

Cullinan Oncology, Inc. is a American stock, trading under the symbol CGEM-Q on the NASDAQ (CGEM). It is usually referred to as NASDAQ:CGEM or CGEM-Q

Is Cullinan Oncology, Inc. a buy or a sell?

In the last year, there was no coverage of Cullinan Oncology, Inc. published on Stockchase.

Is Cullinan Oncology, Inc. a good investment or a top pick?

Cullinan Oncology, Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Cullinan Oncology, Inc..

Why is Cullinan Oncology, Inc. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Cullinan Oncology, Inc. worth watching?

In the last year, there was no coverage of Cullinan Oncology, Inc. published on Stockchase.

What is Cullinan Oncology, Inc. stock price?

On 2023-06-02, Cullinan Oncology, Inc. (CGEM-Q) stock closed at a price of $10.53.